Product Program year 2025 Source: CMS Open Payments

Nasopore

Device Neuro Spine Ent

PDI 07613154340798

Open in the dashboard

General payments

$117,829

378 payments

Research payments

$0

0 payments

Through program year 2025, $117,829 in general payments and $0 in research payments were reported against Nasopore (Neuro Spine Ent).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2025 General $63,807 90
2024 General $21,787 60
2023 General $8,402 48
2022 General $11,533 100
2021 General $12,299 80

Breakdown

Who paid General payments · program years 2021–2025
  1. Stryker Corporation $117,829 378 payments
Top recipients General payments · program year 2025
  1. Raj Sindwani Otolaryngology · Cleveland, OH $19,876 31% · 4 payments
  2. Joseph Capo Otolaryngology · Levittown, NY $9,938 16% · 3 payments
  3. Theodore Truitt Otolaryngology · Saint Cloud, MN $7,650 12% · 1 payment
  4. Joshua Greene Otolaryngology · Anderson, IN $2,875 5% · 3 payments
  5. Jeffrey Suh Otolaryngology · Los Angeles, CA $2,750 4% · 3 payments

The top 5 of 69 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Otolaryngology $56,353 91% · 50 practitioners
  2. Pediatric Otolaryngology Otolaryngology $2,200 4% · 1 practitioner
  3. Otolaryngic Allergy Otolaryngology $1,463 2% · 1 practitioner
  4. Otolaryngology/Facial Plastic Surgery Otolaryngology $1,304 2% · 6 practitioners
  5. Facial Plastic Surgery Otolaryngology $203 <1% · 3 practitioners

The top 5 of 10 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Ohio $19,876 31% · 1 recipient
  2. California $11,938 19% · 10 recipients
  3. New York $11,752 18% · 16 recipients
  4. Minnesota $7,650 12% · 1 recipient
  5. Indiana $4,256 7% · 2 recipients

The top 5 of 17 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

378 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record